Aquestive Therapeutics Inc (AQST)

Other Income/Expenses (Net)

-$25.48M

TTM · Period ending: · USD

AQST logo

AQST Other Income/Expenses (Net)

Latest reported-$25.48M
AQST TTM Other Income/Expenses (Net) (-$8.83M → -$25.48M)
High-resolution chart · PNG

AQST other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aquestive Therapeutics Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
-25,482,000
-13,021,000
-12,733,000
-13,202,000
-12,454,000
-13,074,000
-13,380,000
-13,989,000
-10,568,000
-9,067,000
7,477,000
9,937,000
6,052,000
3,811,000
-12,344,000
-27,981,000
-30,885,000
-33,195,000
-35,860,000
-23,306,000
-19,489,000
-16,368,000
-12,890,000
-10,900,000
-15,540,000
-14,595,000
-13,578,000
-12,441,000
-10,865,000
-12,888,000
-12,442,000
-13,631,000
-9,767,000
-7,798,000
-8,830,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.